A Lung Nodule Is Usually Not Cancer: How Fleischner Follow-Up Actually Works
A scan finds a spot on your lung. The report says nodule, and your mind says cancer. Most of the time it is not. Nodules are common, most are benign, and radiologists have a standard playbook for what to do next. The playbook is almost never a biopsy today. It is a size, a type, and a date on the calendar. The point is the interval, not the panic, and reading a nodule that way is exactly the kind of tracking Healz was built to do.
That playbook has a name. The Fleischner Society, a group of thoracic radiologists, published its current guidelines for incidentally found lung nodules in the journal Radiology in 2017. The guidelines turn a scary word into a plan you can actually follow.
Why most lung nodules turn out to be benign
A pulmonary nodule is just a small, rounded spot in the lung, usually smaller than 3 cm. They show up often, especially now that CT scans are detailed enough to catch tiny ones, and many are found by accident on a scan ordered for something else entirely.
The reassuring part is the math. The Fleischner Society raised its size threshold for routine follow-up in 2017 precisely because screening trials showed the cancer risk in nodules under 6 mm is considerably lower than 1 percent, even in high-risk patients (Fleischner Society 2017, Radiology). Common causes of a benign nodule include scarring or a granuloma from an old, long-healed infection. The nodule is real. It is usually not a tumor.
Ask Healz.
One chat instead of ten apps. 1M+ rare cases checked. The root cause, not the label. Private.
What the radiologist is actually measuring
Three things drive the plan, and it helps to know them before you read your own report.
The first is size, measured in millimeters. Fleischner splits solid nodules into three groups: under 6 mm, 6 to 8 mm, and larger than 8 mm. A single millimeter can move you from no follow-up to a repeat scan, which is why the exact measurement matters.
The second is type. A solid nodule is dense all the way through. A subsolid nodule is fainter, and it comes in two forms, a pure ground-glass nodule (hazy, no solid center) and a part-solid nodule (a hazy area with a denser core). Subsolid nodules follow different timing because they can be slow-growing or, sometimes, an early adenocarcinoma spectrum lesion, so persistence has to be confirmed first (Fleischner Society 2017).
The third is your personal risk. Smoking history, older age, a family history of lung cancer, emphysema, upper-lobe location, and irregular or spiculated edges all push a nodule toward closer follow-up (Fleischner Society, Radiology). If you want to make sense of the raw wording, our guide on how to read a CT scan report walks through the terms line by line.
The Fleischner intervals, by size and type
Here is the part people actually want, translated into plain timing. These apply to a single nodule in an adult 35 or older who is not in one of the excluded groups below. Fleischner deliberately gives ranges, not exact dates, so the radiologist and clinician can weigh your risk (Fleischner Society 2017, Radiology).
For a single solid nodule:
- Under 6 mm, low risk: no routine follow-up.
- Under 6 mm, higher risk: an optional CT at 12 months.
- 6 to 8 mm: a CT at 6 to 12 months, then a CT at 18 to 24 months (considered for low risk, obtained for higher risk).
- Larger than 8 mm: consider a CT at about 3 months, a PET/CT, or tissue sampling.
For a single subsolid nodule:
- Ground-glass under 6 mm: no routine follow-up.
- Ground-glass 6 mm or larger: a CT at 6 to 12 months to confirm it persists, then a CT every 2 years out to 5 years.
- Part-solid under 6 mm: no routine follow-up.
- Part-solid 6 mm or larger: a CT at 3 to 6 months to confirm persistence, then annual CT for 5 years if it stays.
Notice the pattern. Almost nothing here is a rush to biopsy. The plan is to hold the number still and watch whether it changes.
Who Fleischner does not cover
The guidelines are specific about their limits, and this is where people get wrongly reassured or wrongly frightened. Fleischner 2017 does not apply to lung cancer screening programs, to immunocompromised patients, to people with a known primary cancer, or to anyone younger than 35 (Fleischner Society 2017, Radiology).
If you are in a formal low-dose CT screening program, your nodule is scored and followed under Lung-RADS, a different and more intensive system, not Fleischner. If you have an active cancer or a suppressed immune system, a small nodule carries different odds and gets a different workup. Knowing which pathway you are actually on changes what the follow-up date means. For the wider question of what to do when a scan turns up something unexpected, see what to do about an incidental finding.
How Healz tracks a nodule across every scan
A nodule is a number you have to watch over time, and watching is where a single report falls short. Healz is equipped with memory, and it does three things by design: it holds every chest CT and report you upload, it tracks the nodule's size across serial scans, and it compares each new millimeter reading against your own prior baseline. That is how genuine growth gets caught, instead of guessed from one image in isolation.
Around that memory sits the rest of the picture. Healz is a Frontier AI, so its ai ct scan analysis reads the full report in context, the size, the type, the location, the exact wording, not only the impression line. Healz has root-cause technology, so it cross-checks your case against 1M+ rare cases and drills past a vague label to what actually fits your history. It is ai for cancer that keeps the whole thread in one chat, not scattered across ten apps and three patient portals, so a real second opinion on what a nodule means for you stays in one place.
When you want a human in the loop, you can bring a board-certified doctor into the same chat for a second opinion.
Frequently asked questions
- Is a lung nodule always cancer?
No. Most incidentally found lung nodules are benign, and for nodules under 6 mm the estimated cancer risk is well below 1 percent even in higher-risk people (Fleischner Society 2017, Radiology). Common benign causes include scarring or a granuloma from an old infection. Size, type, and your personal risk determine whether any follow-up is needed at all.
- How often should a lung nodule be checked?
It depends on the nodule. Under the Fleischner 2017 guidelines, a small low-risk solid nodule may need no follow-up, a 6 to 8 mm solid nodule is rechecked with a CT at 6 to 12 months and again at 18 to 24 months, and a subsolid nodule 6 mm or larger is confirmed for persistence and then followed for up to 5 years (Fleischner Society, Radiology). The interval is set by size, type, and risk together.
- What is the difference between a solid and a ground-glass nodule?
A solid nodule is dense throughout. A ground-glass nodule is hazier and does not have a solid center, and a part-solid nodule mixes both. Subsolid nodules are followed for longer because they can be slow-growing, so the guidelines first confirm the nodule persists before setting long-term surveillance (Fleischner Society 2017).
- Do the Fleischner guidelines apply to everyone?
No. They do not apply to lung cancer screening, immunocompromised patients, people with a known cancer, or anyone younger than 35 (Fleischner Society 2017, Radiology). Screening nodules are followed under Lung-RADS instead. Confirm which pathway you are on, because it changes what your follow-up plan should be.
A nodule is a size, a type, and a date to watch, not a verdict. The Fleischner guidelines exist to turn a frightening word into a calm interval, and the real work is tracking that number over time. That tracking, holding your scans together and catching change against your own baseline, is exactly what Healz was built to do.
Written by Healz Team · Filed under Health Insights